|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Thoracic and Cardiovascular Surgery, Jean Minjoz Hospital, Boulevard Fleming, Besançon 25000, France
(Email: pierre-emmanuel.falcoz@wanadoo.fr).
| The first 20% of the full text of this article appears below. |
Few studies in the past 10 years have sought to address the interesting question of synchronous primary multiple lung cancer (SPMLC), and they have, for the most part, been retrospective studies focusing on this increasing clinical occurrence and its practical approach. However, very little is known to date about the proportion of patients who actually experience a SPMLC, especially those who would benefit from a surgical resection.
The study by Rostad and associates [1] contributes to our understanding of SPMLC outcomes. They assessed clinical characteristics, short-term and long-term survival in a register population-based study and found that from a total of 15,308 patients diagnosed
Related Article
Ann. Thorac. Surg. 2008 85: 204-209.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |